Jourdeness Group Limited (4190.TW)
TWD 45.25
(-1.52%)
TWD 45.25
(-1.52%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 802.68 Million TWD | -4.35% |
| 2022 | 839.22 Million TWD | -26.25% |
| 2021 | 1.13 Billion TWD | 3.28% |
| 2020 | 1.09 Billion TWD | -21.81% |
| 2019 | 1.4 Billion TWD | 41.28% |
| 2018 | 997.53 Million TWD | 115.8% |
| 2017 | 462.25 Million TWD | -1.54% |
| 2016 | 469.47 Million TWD | -14.86% |
| 2015 | 551.58 Million TWD | 14.7% |
| 2014 | 480.49 Million TWD | -2.06% |
| 2013 | 490.83 Million TWD | 97.5% |
| 2012 | 273.28 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 137.6 Million TWD | -26.71% |
| 2024 Q2 | 111.02 Million TWD | -0.87% |
| 2023 Q1 | 245.08 Million TWD | 36.56% |
| 2023 Q4 | 191.04 Million TWD | 11.93% |
| 2023 Q2 | 276.23 Million TWD | 12.71% |
| 2023 Q3 | 170.68 Million TWD | -38.21% |
| 2023 FY | - TWD | -4.35% |
| 2022 FY | - TWD | -26.25% |
| 2022 Q3 | 181.95 Million TWD | -20.19% |
| 2022 Q1 | 213.08 Million TWD | -32.32% |
| 2022 Q2 | 227.97 Million TWD | 6.99% |
| 2022 Q4 | 179.47 Million TWD | -1.37% |
| 2021 Q2 | 288.39 Million TWD | -1.43% |
| 2021 FY | - TWD | 3.28% |
| 2021 Q4 | 314.85 Million TWD | 30.02% |
| 2021 Q3 | 242.15 Million TWD | -16.03% |
| 2021 Q1 | 292.59 Million TWD | -19.78% |
| 2020 Q2 | 255.66 Million TWD | 50.05% |
| 2020 Q1 | 170.39 Million TWD | -58.24% |
| 2020 Q4 | 364.75 Million TWD | 17.26% |
| 2020 Q3 | 311.06 Million TWD | 21.67% |
| 2020 FY | - TWD | -21.81% |
| 2019 Q1 | 280.72 Million TWD | 5.14% |
| 2019 FY | - TWD | 41.28% |
| 2019 Q4 | 408.02 Million TWD | 26.22% |
| 2019 Q3 | 323.27 Million TWD | -18.62% |
| 2019 Q2 | 397.25 Million TWD | 41.51% |
| 2018 Q4 | 266.99 Million TWD | 13.34% |
| 2018 FY | - TWD | 115.8% |
| 2018 Q1 | 221.26 Million TWD | 97.63% |
| 2018 Q2 | 273.72 Million TWD | 23.71% |
| 2018 Q3 | 235.55 Million TWD | -13.94% |
| 2017 Q4 | 111.95 Million TWD | -3.49% |
| 2017 Q2 | 120.38 Million TWD | 14.36% |
| 2017 Q1 | 105.26 Million TWD | -32.41% |
| 2017 FY | - TWD | -1.54% |
| 2017 Q3 | 116.01 Million TWD | -3.63% |
| 2016 Q1 | 92.9 Million TWD | -35.56% |
| 2016 Q3 | 110.52 Million TWD | 0.21% |
| 2016 FY | - TWD | -14.86% |
| 2016 Q4 | 155.74 Million TWD | 40.92% |
| 2016 Q2 | 110.29 Million TWD | 18.71% |
| 2015 Q1 | 111 Million TWD | -14.42% |
| 2015 FY | - TWD | 14.7% |
| 2015 Q3 | 139.11 Million TWD | -8.11% |
| 2015 Q2 | 151.38 Million TWD | 36.38% |
| 2015 Q4 | 144.18 Million TWD | 3.64% |
| 2014 FY | - TWD | -2.06% |
| 2014 Q4 | 129.7 Million TWD | -8.37% |
| 2014 Q3 | 141.54 Million TWD | 22.37% |
| 2014 Q2 | 115.67 Million TWD | -1.54% |
| 2014 Q1 | 117.48 Million TWD | 65.85% |
| 2013 Q4 | 70.83 Million TWD | 0.0% |
| 2013 FY | - TWD | 97.5% |
| 2012 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Farcent Enterprise Co.,Ltd | 355.04 Million TWD | -126.078% |
| Mao Bao Inc. | 9.01 Million TWD | -8803.905% |
| Taiyen Biotech Co., Ltd. | 518.26 Million TWD | -54.88% |
| Sanitar Co., Ltd. | 401.77 Million TWD | -99.784% |
| Chlitina Holding Limited | 1.96 Billion TWD | 59.23% |
| Nan Liu Enterprise Co., Ltd. | 798.8 Million TWD | -0.486% |
| Luo Lih-Fen Holding Co., Ltd. | 120.7 Million TWD | -564.999% |
| San Neng Group Holdings Co., Ltd. | 336.41 Million TWD | -138.601% |
| Yuen Foong Yu Consumer Products Co., Ltd. | 1.67 Billion TWD | 51.964% |
| KNH Enterprise Co., Ltd. | 1.41 Billion TWD | 43.295% |